134 related articles for article (PubMed ID: 32564106)
1. Parosteal osteosarcoma associated with a low-grade component mimicking well-differentiated liposarcoma: a case report.
Sohier P; Rodrigues M; Anract P; Feydy A; Larousserie F
Skeletal Radiol; 2021 Jan; 50(1):243-248. PubMed ID: 32564106
[TBL] [Abstract][Full Text] [Related]
2. Parosteal osteoliposarcoma: a new bone tumor (from imaging to immunophenotype).
Larousserie F; Chen X; Ding Y; Kreshak J; Cocchi S; Huang X; Niu X; Alberghini M; Vanel D
Eur J Radiol; 2013 Dec; 82(12):2149-53. PubMed ID: 22178310
[TBL] [Abstract][Full Text] [Related]
3. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
[TBL] [Abstract][Full Text] [Related]
4. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
5. Parosteal osteosarcoma with low grade chondrosarcoma and liposarcoma components. A rare histologic variant. Case report and literature review.
Estrada-Villaseñor E; Pichardo-Bahena R; Cedeño-Garcidueñas AL; Delgado-Cedillo EA; Marín-Arriaga N; Arguelles-Pérez DA
Acta Ortop Mex; 2024; 38(2):113-118. PubMed ID: 38782478
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
[TBL] [Abstract][Full Text] [Related]
7. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
8. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis.
He X; Pang Z; Zhang X; Lan T; Chen H; Chen M; Yang H; Huang J; Chen Y; Zhang Z; Jing W; Peng R; Zhang H
Am J Surg Pathol; 2018 Sep; 42(9):1143-1155. PubMed ID: 30001240
[TBL] [Abstract][Full Text] [Related]
9. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
[TBL] [Abstract][Full Text] [Related]
10. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas.
Wunder JS; Eppert K; Burrow SR; Gokgoz N; Bell RS; Andrulis IL
Oncogene; 1999 Jan; 18(3):783-8. PubMed ID: 9989829
[TBL] [Abstract][Full Text] [Related]
11. Two unusual osteogenic orbital tumors: presumed parosteal osteosarcomas of the orbit.
Parmar DN; Luthert PJ; Cree IA; Reid RP; Rose GE
Ophthalmology; 2001 Aug; 108(8):1452-6. PubMed ID: 11470699
[TBL] [Abstract][Full Text] [Related]
12. Sarcomas of fat and bone: a case report.
Honnicke MB; Tharun L; Sieren MM; Barkhausen J
Discov Oncol; 2022 Apr; 13(1):22. PubMed ID: 35384584
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 12q13-15 genes in parosteal osteosarcoma.
Gamberi G; Ragazzini P; Benassi MS; Ferrari C; Sollazzo MR; Molendini L; Merli M; Magagnoli G; Ruggieri P; Balladelli A; Orlando C; Bacchini P; Pazzagli M; Picci P
Clin Orthop Relat Res; 2000 Aug; (377):195-204. PubMed ID: 10943202
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.
Yoshida A; Ushiku T; Motoi T; Shibata T; Beppu Y; Fukayama M; Tsuda H
Mod Pathol; 2010 Sep; 23(9):1279-88. PubMed ID: 20601938
[TBL] [Abstract][Full Text] [Related]
15. Gene amplification and tumor grading in parosteal osteosarcoma.
Chen PC; Yen CC; Hung GY; Pan CC; Chen WM
J Chin Med Assoc; 2019 Dec; 82(12):889-894. PubMed ID: 31634336
[TBL] [Abstract][Full Text] [Related]
16. 12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma.
Kyriazoglou AI; Vieira J; Dimitriadis E; Arnogiannaki N; Teixeira MR; Pandis N
Cancer Genet; 2012 Jun; 205(6):332-6. PubMed ID: 22749040
[TBL] [Abstract][Full Text] [Related]
17. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
18. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
19. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
[TBL] [Abstract][Full Text] [Related]
20. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
